Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study.
Faouzi DjebbariAlexandros RampotasGrant VallanceFotios PanitsasNanda BaskerGina SanghaBeena SalhanFarheen KarimAl-Kaisi FirasAmy GudgerLoretta NguMatt PoyntonHo Pui Jeff LamLowri MorganLaura YangJennifer YoungMairi WalkerIsmini TsagkarakiLaura AndersonSaleena Rani ChauhanRebecca MaddamsRichard SoutarMargarita TriantafillouSteve PrideauxAbubaker ObeidallaToby A EyreCeri BygraveSupratik BasuKarthik RamasamyPublished in: Hematology (Amsterdam, Netherlands) (2022)
Our study described initial results of infection burden during IsaPomDex treatment. We recommend close monitoring particularly in elderly patients with co-morbidities, the effective use of an-infective prophylaxis, as well as optimal vaccination strategies, to limit infections.